Denovo Biopharma Llc

Researchers are testing whether the experimental drug LY2140023 (pomaglumetad methionil) reduces schizophrenia symptoms better than a placebo. The trial enrolls adults diagnosed with schizophrenia who stay in a hospital or clinic during the four-week study. Participants take the …

Researchers are testing whether an experimental drug, LY2140023, eases schizophrenia symptoms better than placebo in people who are acutely ill. The trial also compares it to risperidone, an approved antipsychotic. About 1,100 patients with schizophrenia join this phase 2 study. …

Researchers are testing whether making urine more acidic or more alkaline changes how the body processes an experimental drug called pomaglumetad methionil. In this Phase 1 study, 29 healthy volunteers receive the drug alone, with ammonium chloride to lower urine pH, or with sodi…